(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
IPEC Releases Updated Risk Assessment Guide for Excipient Manufacturers
In May 2025, IPEC Europe announced the release of Version 1 of its revised Risk Assessment Guide for Pharmaceutical Excipients, now available to members via the IPEC website. The guide, expected to be publicly released by mid-2025, replaces the 2017 edition and is now an official IPEC Federation Document.
The updated guide provides a structured framework for excipient manufacturers to assess and manage risks. It includes chapters on risk assessment principles, methods, and manufacturer-specific practices. Key sections are: Introduction, Risk Assessment Principles, Methods, Manufacturer Risk Assessment, and References.
The current table of contents and a summary are accessible on the IPEC site, with the full version to follow in the “Guidelines” section under Resources.
30-06-2025
đź“° Recent News
- FDA Warns Manufacturer Over “Memory-Based” Practices and Unsafe Products
- IPEC Releases Updated Risk Assessment Guide for Excipient Manufacturers
- FDA Issues Warning to OTC Drug Manufacturer for Serious Quality Lapses
- ICH Releases Draft Update of M4Q Guideline for Public Comment
- Malta Flags GMP Violations at Two South African Cannabis Facilities
- EMA Updates Clinical Data Publication Guidelines
- FDA Warns AACE Pharmaceuticals Over Lax CMO Oversight
- FDA Flags Serious GMP Violations at Chinese Drug Facility
- Q’Apel Recalls Stroke Device After FDA Warning
- FDA outlines detailed CAPA Procedure in Warning Letter